Healthcare and Medical/

Fueling the growth of Adult Vaccines Market

Sneha

Fueling the growth of Adult Vaccines Market

The global Adult Vaccines Market is estimated to be valued at US$ 17982.21 Mn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Adult vaccines help protect adults from serious diseases like shingles, tetanus and whooping cough. Adult vaccines provide immunity and protection against diseases. They support better health outcomes and productivity among adults.

Market key trends:

One of the major trends in the adult vaccines market is the growing awareness and focus on immunization programs. Several awareness campaigns by governments across the world are helping drive the demand for adult vaccines. Protecting adults against infectious diseases is important not only for individuals’ health but also helps in community health protection. Additionally, adult immunization offers substantial cost savings to healthcare systems by lowering treatment costs of infectious diseases.

Segment Analysis:

The global adult vaccines market is segmented based on product, disease indication, and distribution channel. The product segment includes conjugate, recombinant, inactivated, and live attenuated vaccines. Among these, the conjugate vaccines segment dominated the market in 2023 due to the high protection they provide against invasive diseases such as meningococcal meningitis and pneumonia.

Key Takeaways:

The Global Adult Vaccines Market Size was valued at US$ 17982.21 Mn in 2023. The market is expected to grow at a CAGR of 7.1% during the forecast period due to the increasing awareness regarding the advantages of adult vaccination and the rising prevalence of diseases preventable through vaccines.

Regional Analysis:

North America dominated the global adult vaccines market in 2023 with a share of over 35.0% owing to the strong presence of key players, growing adoption of adult vaccination products, and higher healthcare expenditure in the region. Asia Pacific is poised to be the fastest-growing market during the forecast period supported by rising disposable incomes, expanding privatization of healthcare facilities, and growing focus on adult vaccination.

Key Players:

Key players operating in the adult vaccines market include GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc. GlaxoSmithKline Plc held the largest market share in 2023 due to its broad portfolio of vaccines for diseases such as influenza, meningococcal, and zoster. Merck & Co. was the second-largest player owning to its strong brands like Gardasil and ProQuad/M-M-R II.

For more insights, read- https://www.insightprobing.com/adult-vaccines-market-size-and-growth-analysis/

Sneha

Adult Vaccines Market Is Estimated To Witness High Growth Owing To Increasing Vaccination Rates

Ben Wood 2023-08-21

The global Adult Vaccines Market is estimated to be valued at US$ 16,790. A) Market Overview: The adult vaccines market refers to the vaccines that are specifically designed for adults to prevent various diseases. B) Market Key Trends: One key trend in the adult vaccines market is the increasing awareness about the benefits of vaccination among adults. - Technological: Technological advancements in vaccine development, delivery systems, and storage methods are facilitating the growth of the adult vaccines market. D) Key Takeaways: - The global adult vaccines market is expected to witness high growth, exhibiting a CAGR of 7.

Adult Vaccines Market Opportunities: Unveiling Preventive Solutions

Roger 2023-12-29

The global adult vaccines market is estimated to be valued at US$ 16,790. 11 million in 2022 and is expected to exhibit a CAGR of 7. Rising Awareness about Vaccine Preventable DiseasesIn the past few years, awareness about potentially life-threatening adult vaccine preventable diseases has increased significantly. This presents a huge opportunity for the adult vaccines market to grow further. Transition from single antigen to multivalent vaccines is viewed as a major trend in the adult vaccines industry.

Adult Vaccines are Estimated to Witness High Growth Owing to Growing Healthcare Expenditure

Omkar Patel 2023-12-22

Increasing prevalence of adult vaccine preventable diseases and growing healthcare expenditure are some of the major factors contributing to the growth of the adult vaccines market. The global adult vaccines market is estimated to be valued at US$ 16,790. Further, high costs associated with adult vaccines as compared to pediatric vaccines is another challenge for the market. Threats: Stringent regulatory framework and lengthy approval process for new adult vaccines may hamper timely introduction of new products. The global Adult Vaccines Market is estimated to be valued at US$ 16,790.

Pneumococcal Vaccines Market Report 2023: R&D Consistency Drives Sector Growth

Ganesh Shinde 2023-01-26

The global Pneumococcal Vaccines Market is expected to grow at a 4. The global market for pneumococcal vaccines is divided into three segments: product type, distribution channel, and region. Based on product type, the market is divided into two categories: pneumococcal conjugate vaccines and pneumococcal polysaccharide vaccines. The distribution channel of public health agencies is expected to be the market leader in the pneumococcal vaccines market. com/reports/pneumococcal-vaccines-marketKey Segments in the Pneumococcal Vaccines MarketBy Product Type:Pneumococcal Polysaccharide VaccinesPneumococcal Conjugate VaccinesBy Distribution Channel:PharmaciesCommunity ClinicsPublic Health AgenciesOthers

Pneumococcal Vaccines Market Industry Analysis, Growth, Trends and Forecast - 2028 | FMI Report

David Lobo 2021-04-02

Future Market Insights (FMI) offers a 10-year forecast on the global pneumococcal vaccines market.

Insights on the key trends, drivers, restraints, value forecasts and opportunities for companies operating in the global pneumococcal vaccines market are presented in the report.The global demand for pneumococcal vaccines is increasing as a result of the large burden of pneumonia-related child mortality rate.

The governments across the globe are focusing on reducing the mortality rate with the help of pneumococcal immunization, which is expected to fuel the growth of the pneumococcal vaccines market.

Opportunity analysis provided in the section allows clients to better equip with crystal clear decision-making insightsTo Get Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-gb-7078The subsequent section of the report provides analysis of the market on the basis of regions and presents forecast in terms of value for the next 10 years.

The company profiles section provides information on the key offerings of each player in the global pneumococcal vaccines market, their direct & indirect presence, revenue, key developments and strategies and SWOT analysis.

The product types covered in the report include:Pneumococcal Polysaccharide VaccinesPneumococcal Conjugate VaccinesThe next section analyses the market on the basis of the distribution channel and presents forecast in terms of value (US$ Mn) for the next 10 years.

Bacterial Vaccines Market is Estimated to Witness High Growth Owing to Opportunity in Prevention of Communicable Diseases

Sumedha 2024-01-03

The global bacterial vaccines market is estimated to be valued at US$ 23. This presents lucrative prospects for manufacturers in the bacterial vaccines market to curb the health burden of communicable illnesses through the development of novel and low-cost vaccines. Competitive rivalry: The global bacterial vaccines market witnesses high competition among major manufacturers to gain maximum market share through novel development and strategic collaborations. Key TakeawaysThe Global Bacterial Vaccines Market Size is expected to witness high growth. Key players operating in the bacterial vaccines market are Mondi Group, Kuraray Co.

WHO TO FOLLOW

MORE FROM AUTHOR

Blarcamesine: A Promising Beacon in the Global Fight Against Neurological Disorders

Sneha 2024-04-26

Morquio Syndrome (MPS-IV) Drug: Updates on Treatment Options for Rare Genetic Disorder Morquio Syndrome

Sneha 2024-04-26

Synthetic Sapphire Market Driven by Growing Demand from LED and Semiconductor Industry

Sneha 2024-04-26

Global Swipe Sensors Market Growth Is Driven By Expanding Smartphone Industry

Sneha 2024-04-26

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

United States Vaccines Market Worth $30 Billion by 2027

Maria Rai 2021-10-26

Use Coupon Code : DPI30United States Vaccines Market research report includes market objectives and scopes during the projected period by highlighting key market segments and leading players.The United States vaccines market size is projected to touch the figures of USD 30 Billion by 2027.Download Free Sample Report @ https://dpiresearch.com/request-a-free-sample-reportHighlighted with 19 tables and 93 figures, this 195-page report “United States Vaccines Market Size, Top 45 Vaccines Brand In-depth Analysis, Trends, Shares, Insights, and Forecasts to 2027” is based on comprehensive research of the United States vaccines market.

The report provides historical market data for 2018 – 2020, and forecasts from 2021 until 2027.

The report provides a clear insight into current and future developments of the United States vaccines market.

The report also details the latest information about the vaccine’s pricing analysis, insights, and trends, and the regulatory framework of the United States vaccines market.The report also tracks and analyses competitive developments, including collaboration, partnership deals, distribution, exclusive and licensing agreements, new vaccine developments, and R activities in the market.

The report also delivers an in-depth analysis of evolving market trends, drivers, and restraining forces that influence the growth of the market.The report also analyses detailed profiles of innovative and leading players with information on business overview, companies’ vaccines portfolio, promising vaccines in the clinical development, and the latest developmentsEnquire for customization in Report @: https://dpiresearch.com/services/custom-research-services-providing-focused-comprehensive-tailored-research/This Comprehensive U.S Vaccines Report Provides:The Market Size of the United States Vaccines Market with Six Years ForecastDetailed Insights of the Top 45 Vaccines Market Value Used in the U.S. with Six Years ForecastAn Insightful Analysis of the Top 45 Vaccines Brand Market Share and Y-o-Y Growth RateDelivers Comprehensive Insights on the Latest Pricing Analysis, Insights, and TrendsDelivers an In-Depth Analysis of Evolving Market Trends, Drivers and Restraints of the United States Vaccines MarketAn Insightful Investigation has been done on Promising Vaccines in the Clinical DevelopmentDelivers Comprehensive Insights into the Regulatory Framework of the United States Vaccines MarketTracks Competitive Developments, Approaches, Recent Industry Developments, Partnership, Collaboration Deals, Distribution, Exclusive, and Licensing AgreementA Comprehensive List of the Leading Companies along with the Analysis of their Current Vaccines Portfolio, Promising Vaccines in the Clinical Development, and Recent DevelopmentThe Leading Companies for the U.S Vaccines Market are Listed Below:PfizerMerckGrifolsSanofi PasteurSeqirus (CSL Limited)AstraZenecaGlaxoSmithKline (GSK)Dynavax Technologies CorporationThe Following 45 Leading Vaccines Brand are Detailed with Market Value and Six-Years Forecast:DaptacelQuadracelKinrixPentacelVaxelisIPOLVaqtaHavrixTwinrixEngerix BRecombivax HBPedvaxHIBActHIBHiberixMenQuadfiTenivacImovaxPrevnar 13Gardasil 9FluzoneFlublokFluadVarivaxMenactraProquadPneumovax 23Fluarix/FluLavalM–M–R IIAdacelBoostrixBexseroMenveoTrumenbaShingrixPentacelRecombivax HBRotateqRotarixPediarix/InfanrixHeplisav–BTDVAXFluMist QuadrivalentHavrix/Twinrix/Engerix–BFlucelvax QuadrivalentAfluria QuadrivalentThe Report Helps Answer the Following Questions:What is the current scenario of the United States vaccines market?What is the total market size and forecast (until 2027) for the United States vaccines market?What are the leading vaccines?

What are their revenue potentials to 2027?Which vaccine provides the highest market share?What is the regulatory framework in the United States vaccines market?What are the major growth drivers of the United States vaccines market?What are the major inhibitors of the United States vaccines market?What are the major deals and agreement happenings in the United States vaccines market?What are the United States vaccines pricing trends and analysis?What are the various vaccines available in the United States?Who are the top market players?

Driving Factors and Key Players in the Porcine Vaccines Market

Ashish Thapa 2023-07-19

Several driving factors are propelling the growth of the porcine vaccines market, while key players in the industry play a crucial role in shaping its trajectory. One of the primary driving factors in the Porcine Vaccines Market is the increasing prevalence of swine diseases. Such initiatives create a favorable environment for the development, manufacturing, and distribution of porcine vaccines, driving the market forward. Conjugate Vaccines in the Porcine Vaccines Market have been developed to target diseases such as porcine circovirus, swine influenza, and porcine reproductive and respiratory syndrome. In terms of key players, the Porcine Vaccines Market is dominated by pharmaceutical companies and vaccine manufacturers.

Global Veterinary Vaccines Market Is Estimated To Witness High Growth Owing To Increasing Pet Adoption and Rising Prevalence of Animal Diseases

Yashvi Gadhiya 2023-08-22

The global Veterinary Vaccines Market is estimated to be valued at US$8,482. Growing pet adoption and rising prevalence of animal diseases are driving the demand for veterinary vaccines globally. This has led to an increased demand for veterinary vaccines to ensure the health and well-being of these pets. Driver: Rising prevalence of animal diseasesThe increasing prevalence of various infectious diseases among animals is driving the demand for veterinary vaccines. 2% over the forecast period, due to increasing pet adoption and rising prevalence of animal diseases.

Analyzing the Dynamics of the Zambia Cholera Vaccines Market

Sneha 2024-03-28

The Zambia Cholera Vaccines Market exhibits a complex interplay of factors influencing its growth and sustainability. Key Takeaways:The Zambia Cholera Vaccines Market is characterized by a growing need for effective preventive measures against cholera outbreaks in the region. SWOT Analysis:A SWOT analysis provides insights into the strengths, weaknesses, opportunities, and threats within the Zambia Cholera Vaccines Market. Geographical Regions:Geographical regions play a pivotal role in shaping the dynamics of the Zambia Cholera Vaccines Market. The Zambia Cholera Vaccines Market is vital in combating the persistent threat of cholera outbreaks in the region.

Influenza Vaccines Market Trends, Comprehensive Analysis, Company Latest News and Forecast to 2025

Anjali Pawar 2023-04-20

The global influenza vaccines market is anticipated to witness significant growth from 2021 to 2025, driven by factors such as increasing prevalence of influenza, growing awareness about vaccination, and rising government initiatives to promote vaccination programs. Based on vaccine type, the market is segmented into trivalent influenza vaccines and quadrivalent influenza vaccines. The quadrivalent influenza vaccines segment is expected to witness significant growth over the forecast period, owing to the increasing demand for vaccines that can protect against four different influenza viruses. Based on technology, the Influenza Vaccines Market is segmented into egg-based vaccines, cell culture-based vaccines, and recombinant-based vaccines. The cell culture-based vaccines segment is expected to witness significant growth over the forecast period, owing to the advantages of cell culture-based vaccines over egg-based vaccines. Based on vaccine type, the market is segmented into trivalent influenza vaccines and quadrivalent influenza vaccines. The quadrivalent influenza vaccines segment is expected to witness significant growth over the forecast period, owing to the increasing demand for vaccines that can protect against four different influenza viruses.

From Preventing To Protection: Understanding Influenza Vaccines

shradha bhandare 2023-05-31

The main method for minimising or combating the burden of influenza mortality and morbidity in the population is influenza vaccination. The selection and development of ideal candidate Influenza vaccines viruses, as well as the development and accessibility of vaccine potency reagents, are prerequisites for the manufacturing and supply of an effective influenza vaccine. Based on data from the WHO Global Influenza Surveillance Network (GISN), now known as the WHO Global Influenza Surveillance and Response System, several recommendations have been made. Since 2004, GISRS has also taken into account influenza A (H5N1), A (H9N2), and other subtypes of influenza viruses for pandemic preparedness reasons. Explain interprofessional team strategies for improving care coordination and communication to advance influenza vaccination and improve patient outcomes.

Therapeutic Vaccines Market Will Grow At Highest Pace Owing To Rising Demand For Cancer Treatment

Pooja Khodke 2024-02-13

The rising prevalence of cancer and infectious diseases worldwide has fueled the demand for therapeutic vaccines. Some key therapeutic cancer vaccines currently in development target cancers such as melanoma, prostate cancer, breast cancer and leukemia. The Global Therapeutic Vaccines Market is estimated to be valued at Us$ 3. Growing demand: The rising prevalence of cancer globally is a major factor driving the demand for therapeutic cancer vaccines. The COVID-19 pandemic has impacted the growth of the therapeutic vaccines market.

Influenza Vaccines Market Growing Demand Stimulated by Higher Prevalence of Influenza Diseases

Mia Yates 2024-01-10

The global influenza vaccines market is estimated to be valued at US$ 6216. Additionally, increasing awareness regarding importance of seasonal flu vaccination for at risk population has stimulated the uptake of influenza vaccines. Segment Analysis The global Influenza Vaccines market is dominated by the quadrivalent vaccines sub-segment. These vaccines protect against four strains of influenza virus (two influenza A strains and two influenza B strains) as compared to trivalent vaccines that protect against three strains. Quadrivalent vaccines offer broader protection against influenza viruses and are able to target more strains circulating during any given flu season.

Global Influenza Vaccines Market Is Estimated To Witness High Growth

Larry Paige 2023-08-21

The global Influenza Vaccines Market is estimated to be valued at US$ 5,965. B) Market Dynamics:The market for influenza vaccines is driven by two major factors. C) Market Key Trends:One key trend observed in the influenza vaccines market is the development of universal influenza vaccines. E) Key Takeaways:- The global influenza vaccines market is expected to witness high growth, exhibiting a CAGR of 4. In conclusion, the global influenza vaccines market is poised for significant growth in the coming years.

IPV Vaccines Market Estimated To Witness High Growth Due To The Recent Launches Of Novel Combination IPV Vaccines

samruddhicmi123 2023-11-01

The Global IPV Vaccines Market is estimated to be valued at US$ 160 Mn in 2023 and is expected to exhibit a CAGR of 8. Based on product type, the market can be bifurcated into oral polio vaccine and inactivated polio vaccine. Currently, the inactivated polio vaccine segment dominates the market due to greater efficacy and longer duration of immunity compared to oral polio vaccine. The Asia Pacific region is projected to be the fastest-growing market for IPV vaccines during the forecast period, expanding at a CAGR of around 9%. This can be attributed to high burden of polio cases, increasing healthcare expenditure, and strengthening immunization programs in various Asia Pacific countries.

Global Cancer Vaccines Market Is Estimated To Witness High Growth Owing to Increasing Demand for Cancer Treatment and Favorable Government Initiatives

Cmitejashree 2023-08-16

The global cancer vaccines market is estimated to be valued at US$4,188 million in 2019 and is expected to exhibit a CAGR of 12. The increasing prevalence of cancer worldwide is driving the demand for innovative treatment options, including cancer vaccines. Personalized cancer vaccines are tailored to an individual patient's genetic profile and tumor characteristics, leading to improved treatment outcomes. 6% over the forecast period, due to increasing demand for cancer treatment and favorable government initiatives. However, challenges such as high development costs and regulatory requirements must be overcome to fully realize the potential of cancer vaccines in improving patient outcomes.

Navigating the Regulatory Landscape of the Therapeutic Vaccines Market (2022-2028)

Pooja salve 2023-07-27

The Therapeutic Vaccines Market is a dynamic and rapidly evolving sector that holds tremendous potential for revolutionizing disease treatment. As novel therapeutic vaccines emerge, navigating the complex regulatory landscape becomes crucial to ensure patient safety, efficacy, and market access. Addressing Immunogenicity and Autoimmunity:One of the critical challenges in therapeutic vaccine development is addressing immunogenicity and potential autoimmune reactions. Global Harmonization of Regulatory Standards:The Therapeutic Vaccines Market operates on a global scale, necessitating harmonization of regulatory standards across different regions. Conclusion:As the Therapeutic Vaccines Market continues to advance, navigating the regulatory landscape becomes a pivotal aspect of bringing innovative therapies to patients.

Tuberculosis Vaccines: Empowering Communities for Sustainable Change

gauri kanale 2023-06-21

By prioritizing community engagement, awareness, and access to Tuberculosis Vaccines, we can create a collective effort towards disease control and prevention. Informed communities become active participants in disease prevention, advocating for Tuberculosis Vaccines and ensuring their uptake within their social networks. By bringing vaccines directly to communities, we remove barriers such as distance, transportation, and limited healthcare infrastructure, ensuring that everyone has an equal opportunity to protect themselves and their loved ones from tuberculosis. Researchers are exploring new vaccine candidates, such as M72/AS01E and H4:IC31, to provide improved protection against tuberculosis. com/article/tuberculosis-vaccines-are-essential-for-stopping-the-infection-from-spreading-and-reducing-symptoms-of-the-disease

Emerging Trends and Growth Prospects in the Zambia Cholera Vaccines Market

Ishika cmi 2024-03-05

The Zambia cholera vaccines market is witnessing several notable trends that are shaping its growth trajectory and are expected to influence market dynamics in the forecast period. One prominent trend is the integration of cholera vaccination into broader public health strategies aimed at addressing water, sanitation, and hygiene (WASH) issues. Recognizing the interconnectedness of cholera prevention and WASH interventions, the Zambian government and healthcare authorities are implementing holistic approaches to combat cholera outbreaks by improving access to clean water, promoting hygiene practices, and expanding cholera vaccination coverage. Mobile vaccination clinics, community outreach programs, and door-to-door vaccination campaigns are being employed to overcome logistical challenges and ensure equitable access to cholera vaccines across the country. By addressing the underlying determinants of cholera transmission, expanding vaccination coverage, and strengthening public health systems, Zambia is poised to make significant strides in cholera prevention and control.

United States Vaccines Market Worth $30 Billion by 2027

Maria Rai 2021-10-26

The report provides historical market data for 2018 – 2020, and forecasts from 2021 until 2027.

The report provides a clear insight into current and future developments of the United States vaccines market.

Global Influenza Vaccines Market Is Estimated To Witness High Growth

Larry Paige 2023-08-21

Driving Factors and Key Players in the Porcine Vaccines Market

Ashish Thapa 2023-07-19

IPV Vaccines Market Estimated To Witness High Growth Due To The Recent Launches Of Novel Combination IPV Vaccines

samruddhicmi123 2023-11-01

Global Veterinary Vaccines Market Is Estimated To Witness High Growth Owing To Increasing Pet Adoption and Rising Prevalence of Animal Diseases

Yashvi Gadhiya 2023-08-22